StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CytoMed Therapeutics's total debt was 409.50K SGD at Dec 31, 2025. For fiscal 2025 it was 409.50K SGD, down 5.2% from the year before. The highest annual figure on record is 924.81K SGD in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025409.50K SGD-5.2%
FY2024Dec 31, 2024431.96K SGD-2.2%
FY2023Dec 31, 2023441.70K SGD-45.0%
FY2022Dec 31, 2022803.61K SGD-13.1%
FY2021Dec 31, 2021924.81K SGD–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025409.50K SGD-55.7%
Q4 FY2024Dec 31, 2024431.96K SGD–
Q4 FY2023Dec 31, 2023441.70K SGD–
Q4 FY2022Dec 31, 2022803.61K SGD–
Q4 FY2021Dec 31, 2021924.81K SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?